The Impact of Fish Oil Supplementation on the Outcome of Children with Pneumonia I

NCT06005454 | Completed DMC

• 1 other identifier: MS-369-2022
• Study Type: interventional
• Target: 122
• Locations: 1 country
• Sites: 1

Brief Summary

The aim of study is to investigate the effect of enteral feeding of Omega-3 on the outcome of children with Pneumonia in PICU

Conditions

Pneumonia

Outcome Measures

Primary Outcomes (1)

• Hospital length stay

  Hospital length stay will be measured between the two groups

  Through study completion, an average of 1 yea

Study Arms (2)

Children with Pneumonia in intensive care unit receiving fish oil and the standard treatment

EXPERIMENTAL

Dietary Supplement: Fish oil (Omega)

Children with Pneumonia in intensive care unit receiving the standard treatment only

NO INTERVENTION

Interventions

Fish oil (Omega) DIETARY_SUPPLEMENT

We will use a dietary supplement source of omega 3 fatty acids from the available syrup ( each 5 ml contain 640 mg of high DHA Fish oil) so we will give it in a dose 2.7 ml twice daily for children between 1 and 3 years and 3.5 ml twice daily for children between 4 and 5 years.

Children with Pneumonia in intensive care unit receiving fish oil and the standard treatment

Eligibility Criteria

• Age: 1 Month - 5 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Child (0-17)

You may qualify if:

• All children patients with severe pneumonia admitted to PICU
• Both sexes
• Age: under 5 years
• Whose parents or caregivers approve for participation in the study

You may not qualify if:

• Patients with chronic illnesses to exclude bias that could be emerged due to the chronic disease effect
• Whose parents or caregivers will not apply for participation in the study
• Patients who will be contraindicated for enteral feeding

Sponsors & Collaborators

• Cairo University: lead

Study Sites (1)

Hoda Atef Abdelsattar Ibrahim

Cairo, Egypt

Location

MeSH Terms

Conditions

Pneumonia

Interventions

Fish Oils

Condition Hierarchy (Ancestors)

Respiratory Tract Infections; Infections; Lung Diseases; Respiratory Tract Diseases

Intervention Hierarchy (Ancestors)

Oils; Lipids

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: INVESTIGATOR
• Purpose: PREVENTION
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Dr

Model Details: Randomized Controlled Trial

Study Record Dates

• First Submitted: August 10, 2023
• First Posted: August 22, 2023
• Study Start: September 1, 2023
• Primary Completion: September 11, 2024
• Study Completion: October 11, 2024
• Last Updated: March 19, 2025

Record last verified: 2025-03

Data Sharing

• IPD Sharing: Will not share

Locations

EG (1)